A detailed history of Stonebridge Financial Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stonebridge Financial Group, LLC holds 4,984 shares of BMY stock, worth $233,301. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,984
Previous 8,551 41.71%
Holding current value
$233,301
Previous $386 Million 30.29%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 20, 2026

SELL
$42.6 - $49.08 $151,954 - $175,068
-3,567 Reduced 41.71%
4,984 $269 Million
Q3 2025

Oct 20, 2025

SELL
$43.31 - $48.98 $26,938 - $30,465
-622 Reduced 6.78%
8,551 $386 Million
Q2 2025

Jul 24, 2025

SELL
$44.12 - $59.6 $838 - $1,132
-19 Reduced 0.21%
9,173 $425 Million
Q1 2025

Apr 25, 2025

SELL
$53.9 - $63.11 $34,873 - $40,832
-647 Reduced 6.58%
9,192 $561 Million
Q4 2024

Jan 29, 2025

BUY
$51.92 - $59.94 $510,840 - $589,749
9,839 New
9,839 $556 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Stonebridge Financial Group, LLC Portfolio

Follow Stonebridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Financial Group, LLC with notifications on news.